IA
ANAC

IFP Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

IFP Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,041
Closed -$118K – 4590
2015
Q4 		$118K Buy
+1,041
New +$115K 0.01% 1087

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

IFP Advisors's ANAC Position: Q1 2016 in Review

IFP Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 1,041 shares — an estimated $118K sold.

IFP Advisors first reported a position in ANAC in Q4 2015 and held it in 1 quarter. The position peaked at $118K in Q4 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

  • IFP Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
  • IFP Advisors sold 1,041 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $118K.
  • IFP Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2015 and held it in 1 quarter.
  • IFP Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $118K in Q4 2015.
  • 199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on IFP Advisors's 13F filing for Q1 2016, filed 2 May 2016.